NDC 0169-4060

Victoza

Liraglutide

Victoza is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Liraglutide.

Product ID0169-4060_15c86a89-8747-40bc-8339-287e8785bba9
NDC0169-4060
Product TypeHuman Prescription Drug
Proprietary NameVictoza
Generic NameLiraglutide
Dosage FormInjection
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2010-01-25
Marketing CategoryNDA / NDA
Application NumberNDA022341
Labeler NameNovo Nordisk
Substance NameLIRAGLUTIDE
Active Ingredient Strength6 mg/mL
Pharm ClassesGLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0169-4060-12

2 SYRINGE, PLASTIC in 1 CARTON (0169-4060-12) > 3 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2010-01-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0169-4060-12 [00169406012]

Victoza INJECTION
Marketing CategoryNDA
Application NumberNDA022341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-01-25

NDC 0169-4060-90 [00169406090]

Victoza INJECTION
Marketing CategoryNDA
Application NumberNDA022341
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-01-25

NDC 0169-4060-97 [00169406097]

Victoza INJECTION
Marketing CategoryNDA
Application NumberNDA022341
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-10-15
Marketing End Date2015-03-31

NDC 0169-4060-99 [00169406099]

Victoza INJECTION
Marketing CategoryNDA
Application NumberNDA022341
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-13

NDC 0169-4060-98 [00169406098]

Victoza INJECTION
Marketing CategoryNDA
Application NumberNDA022341
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-04-15
Marketing End Date2016-11-30

NDC 0169-4060-13 [00169406013]

Victoza INJECTION
Marketing CategoryNDA
Application NumberNDA022341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-01-25

Drug Details

Active Ingredients

IngredientStrength
LIRAGLUTIDE6 mg/mL

OpenFDA Data

SPL SET ID:5a9ef4ea-c76a-4d34-a604-27c5b505f5a4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897122
  • 897126
  • Pharmacological Class

    • GLP-1 Receptor Agonist [EPC]
    • Glucagon-Like Peptide 1 [CS]
    • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

    NDC Crossover Matching brand name "Victoza" or generic name "Liraglutide"

    NDCBrand NameGeneric Name
    0169-4060Victozaliraglutide
    50090-2853Victozaliraglutide
    50090-4503Victozaliraglutide
    0169-2800Saxendaliraglutide
    50090-4257Saxendaliraglutide

    Trademark Results [Victoza]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VICTOZA
    VICTOZA
    76477425 2806406 Live/Registered
    Novo Nordisk A/S
    2002-12-20

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.